The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity

Journal of Child Neurology

Volumn 26, Issue 12, 2011, Pages 1522-1524

  Castro Gago, Manuel ^a   Pérez Gay, Laura ^a   Gómez Lado, Carmen ^a   Castiñeiras Ramos, Daisy E ^b   Otero Martínez, Santiago ^b   Rodríguez Segade, Santiago ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

Author keywords

biotin; biotinidase; carbamazepine; valproic acid; zinc

Indexed keywords

BIOTIN; BIOTINIDASE; CARBAMAZEPINE; VALPROIC ACID; ZINC;

ALOPECIA; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; COLORIMETRY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HAIR LOSS; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; ZINC BLOOD LEVEL;

ADOLESCENT; ANTICONVULSANTS; BIOTIN; BIOTINIDASE; CARBAMAZEPINE; CHILD; FEMALE; HUMANS; MALE; SEIZURES; VALPROIC ACID; ZINC;

EID: 82455187852     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073811409227     Document Type: Conference Paper

References (23)

1. Wilder BJ. Gastrointestinal tolerance of sodium valproate. Neurology. 1983 ; 33: 808-811
2. McKinney PA, Finkebine RD, DeVane CI. Alopecia and mood stabilizer therapy. Ann Clin Psychiatry. 1996 ; 8: 183-185 (Pubitemid 26372319)
3. Wallace SJ. A comparative review of the adverse effects of anticonvulsants in children with epilepsy. Drug Saf. 1996 ; 15: 379-393
4. Dreifuss FE.. Valproic acid toxicity. Antiepileptic drugs. 1996 ;: 641-648
5. Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr. 1982 ; 101: 782-785 (Pubitemid 12006715)
6. Castro-Gago M, Novo I, Rodríguez-Segade S. Effects of valproic acid on the urea cycle and carnitine metabolism. Int Pediatr. 1990 ; 5: 54-57 (Pubitemid 20328244)
7. Castro-Gago M, Eirís-Puñal J, Novo-Rodríguez MI, et al. Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital. J Child Neurol. 1998 ; 13: 546-549 (Pubitemid 29029808)
8. Schulpis KH, Karikas GA, Tjamouranis J, et al. Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia. 2001 ; 42: 1359-1362 (Pubitemid 33070678)
9. Yilmaz Y, Tasdemir HA, Paksu MS. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol. 2009 ; 13: 439-443
10. Korkmazer N, Vurucu S, Demirkaya E, et al. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid. Brain Dev. 2006 ; 28: 515-520 (Pubitemid 44051826)
11. Arslan M, Vurucu S, Balamtekin N, et al. The effects of biotin supplementation on serum and liver tissue biotinidase activity and alopecia in rats which were administrated to valproic acid. Brain Dev. 2009 ; 31: 405-410
12. Krause K-H, Berlit P, Bonjour J-P.. Impaired biotin status in anticonvulsant therapy. Ann Neurol. 1982 ; 12: 485-486 (Pubitemid 12006886)
13. Krause K-H, Kochen W, Berlit P, Bonjour J-P. Excretion of organic acids associated with biotin deficiency in chronic anticonvulsant therapy. Int J Vitam Nutr Res. 1984 ; 54: 217-222 (Pubitemid 14039281)
14. Krause K-H, Bonjour J-P, Berlit P, Kochen W. Biotin status of epileptics. Ann N Y Acad Sci. 1985 ; 447: 297-313 (Pubitemid 15037942)
15. Krause KH, Bonjour JP, Berlit P, et al. Effect of long-term treatment with antiepileptic drugs on the vitamin status. Drug Nutr Interact. 1988 ; 5: 317-343 (Pubitemid 19020793)
16. Castro-Gago M, Gómez-Lado C, Eirís-Puñal J, et al. Serum biotinidase activity in children treated with valproic acid and carbamazepine. J Child Neurol. 2010 ; 25: 32-35
17. Anagnostouli M, Livaniou E, Nyalala JO, et al. Cerebrospinal fluid levels of biotin in various neurological disorders. Acta Neurol Scand. 1999 ; 99: 387-392 (Pubitemid 29253983)
18. Armutcu F, Ozerol E, Gurel A, et al. Effect of long-term therapy with sodium valproate on nail and serum trace element status in epileptic children. Biol Trace Elem Res. 2004 ; 102: 1-10 (Pubitemid 40105001)
19. Graf WD, Oleinik OE, Glauser TA, et al. Altered antioxidant enzyme activities in children with serious adverse experience related to valproic acid therapy. Neuropediatrics. 1998 ; 29: 195-201 (Pubitemid 28396070)
20. Altunbasak S, Biatmakoui F, Baytok V, et al. Serum and hair zinc levels in epileptic children taking valproic acid. Biol Trace Elem Res. 1997 ; 58: 117-125 (Pubitemid 27485819)
21. Kaji M, Ito M, Okuno T, et al. Serum copper and zinc levels in epileptic children with valproate treatment. Epilepsia. 1992 ; 33: 555-557
22. Verrotti A, Basciani F, Trotta D, et al. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res. 2002 ; 48: 71-75 (Pubitemid 34127718)
23. Plonka-Póltorak E, Zagrodzki P, Chlopicka J, et al Biol Trace Elem Res. 2011: